Judith M. Hyatt

1.3k total citations
13 papers, 1.1k citations indexed

About

Judith M. Hyatt is a scholar working on Pharmacology, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Judith M. Hyatt has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Molecular Medicine and 6 papers in Applied Microbiology and Biotechnology. Recurrent topics in Judith M. Hyatt's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotic Use and Resistance (6 papers). Judith M. Hyatt is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotic Use and Resistance (6 papers). Judith M. Hyatt collaborates with scholars based in United States and Armenia. Judith M. Hyatt's co-authors include Jerome J. Schentag, Peggy S. McKinnon, Alan Forrest, Charles H. Ballow, Angela Cheng, Jennifer Thomas, Sujata M. Bhavnani, David E. Nix, Joseph A. Paladino and Thomas J. Cumbo and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Judith M. Hyatt

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith M. Hyatt United States 11 823 523 429 265 198 13 1.1k
Christina Sutherland United States 21 712 0.9× 577 1.1× 373 0.9× 207 0.8× 227 1.1× 45 1.1k
Melinda K. Lacy United States 12 537 0.7× 316 0.6× 422 1.0× 170 0.6× 150 0.8× 21 1.0k
Cynthia L. Fowler United States 16 617 0.7× 360 0.7× 639 1.5× 118 0.4× 115 0.6× 21 1.1k
C H Nightingale United States 17 657 0.8× 325 0.6× 427 1.0× 115 0.4× 115 0.6× 37 1.0k
C Andrew DeRyke United States 17 639 0.8× 636 1.2× 401 0.9× 338 1.3× 194 1.0× 60 1.1k
András Farkas United States 6 624 0.8× 246 0.5× 344 0.8× 206 0.8× 130 0.7× 13 772
Anthony M. Nicasio United States 15 596 0.7× 474 0.9× 371 0.9× 232 0.9× 73 0.4× 18 779
Catharine C. Bulik United States 18 739 0.9× 736 1.4× 415 1.0× 255 1.0× 140 0.7× 26 1.0k
Pamela R. Tessier United States 19 675 0.8× 511 1.0× 648 1.5× 107 0.4× 114 0.6× 41 1.1k
Sandrine Lefeuvre France 17 494 0.6× 190 0.4× 362 0.8× 131 0.5× 91 0.5× 36 928

Countries citing papers authored by Judith M. Hyatt

Since Specialization
Citations

This map shows the geographic impact of Judith M. Hyatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith M. Hyatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith M. Hyatt more than expected).

Fields of papers citing papers by Judith M. Hyatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith M. Hyatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith M. Hyatt. The network helps show where Judith M. Hyatt may publish in the future.

Co-authorship network of co-authors of Judith M. Hyatt

This figure shows the co-authorship network connecting the top 25 collaborators of Judith M. Hyatt. A scholar is included among the top collaborators of Judith M. Hyatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith M. Hyatt. Judith M. Hyatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Elman, Igor, Steven B. Lowen, Kevin G. Lynch, et al.. (2015). Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence. Translational Psychiatry. 5(3). e531–e531. 34 indexed citations
2.
Hyatt, Judith M., et al.. (2013). Toolbox: Neuropsychiatric adverse effects of antimicrobial agents. Mental Health Clinician. 3(5). 219–243. 1 indexed citations
3.
Hyatt, Judith M. & Jerome J. Schentag. (2000). Potential Role of Pharmacokinetics, Pharmacodynamics, and Computerized Databases in Controlling Bacterial Resistance. Infection Control and Hospital Epidemiology. 21(S1). S18–S21. 11 indexed citations
4.
Hyatt, Judith M. & Jerome J. Schentag. (2000). Pharmacodynamic Modeling of Risk Factors for Ciprofloxacin Resistance in Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology. 21(S1). S9–S11. 33 indexed citations
5.
Hyatt, Judith M., et al.. (2000). Pharmacokinetic/pharmacodynamic predictors of time to clinical resolution in patients with acute bacterial exacerbations of chronic bronchitis treated with a fluoroquinolone. International Journal of Antimicrobial Agents. 16(3). 273–280. 8 indexed citations
7.
Thomas, Jennifer, Alan Forrest, Sujata M. Bhavnani, et al.. (1998). Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy. Antimicrobial Agents and Chemotherapy. 42(3). 521–527. 394 indexed citations
8.
Nix, David E., William T. Symonds, Judith M. Hyatt, et al.. (1997). Comparative Pharmacokinetics of Oral Ceftibuten, Cefixime, Cefaclor, and Cefuroxime Axetil in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(1). 121–125. 22 indexed citations
9.
Hyatt, Judith M., Aileen B Luzier, Alan Forrest, Charles H. Ballow, & Jerome J. Schentag. (1997). Modeling the response of pneumonia to antimicrobial therapy. Antimicrobial Agents and Chemotherapy. 41(6). 1269–1274. 10 indexed citations
10.
Schentag, Jerome J., Mary C. Birmingham, Joseph A. Paladino, et al.. (1997). In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.. PubMed. 12(4). 278–93. 23 indexed citations
11.
Hyatt, Judith M., et al.. (1995). The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to Outcome. Clinical Pharmacokinetics. 28(2). 143–160. 322 indexed citations
12.
Hyatt, Judith M., David E. Nix, Charles W. Stratton, & Jerome J. Schentag. (1995). In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 39(8). 1711–1716. 36 indexed citations
13.
Hyatt, Judith M., David E. Nix, & Jerome J. Schentag. (1994). Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar. Antimicrobial Agents and Chemotherapy. 38(12). 2730–2737. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026